{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:00:27Z","timestamp":1790298027103,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pupt.2026.102450","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:02:02Z","timestamp":1790175722000},"page":"102450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting pulmonary and arterial chemoreceptors via inhaled therapeutics: A novel pathway to blunt hypoxia-induced pulmonary hypertension?"],"prefix":"10.1016","volume":"95","author":[{"given":"Durlav","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-8337","authenticated-orcid":false,"given":"Surendra H.","family":"Bodakhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.pupt.2026.102450_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011023","article-title":"mTOR in the development of hypoxic pulmonary hypertension associated with cardiometabolic risk factors","volume":"25","author":"Flores","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.pupt.2026.102450_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101129","article-title":"Advanced treatment strategies for high-altitude pulmonary hypertension employing natural medicines: a review","volume":"15","author":"Batool","year":"2025","journal-title":"J. Pharm. Anal."},{"issue":"21","key":"10.1016\/j.pupt.2026.102450_bib2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jacc.2023.09.806","article-title":"Sleep-related Hypoxia, right ventricular dysfunction, and survival in patients with group 1 pulmonary arterial hypertension","volume":"82","author":"Lowery","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib3","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1038\/s41598-024-59367-y","article-title":"OPN silencing reduces hypoxic pulmonary hypertension via PI3K-AKT-induced protective autophagy","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.pupt.2026.102450_bib4","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.3390\/ijms25137484","article-title":"Pulmonary vascular responses to chronic intermittent hypoxia in a Guinea pig model of obstructive sleep apnea","volume":"25","author":"Olea","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.pupt.2026.102450_bib5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1113\/JP277190","article-title":"Carotid chemoreflex activity restrains post-exercise cardiac autonomic control in healthy humans and in patients with pulmonary arterial hypertension","volume":"597","author":"Paula-Ribeiro","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.pupt.2026.102450_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1509421","article-title":"Excess ventilation and chemosensitivity in patients with inefficient ventilation and chronic coronary syndrome or heart failure: a case-control study","volume":"15","author":"Eser","year":"2025","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pupt.2026.102450_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-physiol-020518-114427","article-title":"Physiology of the carotid body: from molecules to disease","volume":"82","author":"Ortega-S\u00e1enz","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.pupt.2026.102450_bib54","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16247.1","article-title":"Recent advances in understanding the physiology of hypoxic sensing by the carotid body","volume":"7","author":"Prabhakar","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.pupt.2026.102450_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40659-016-0073-8","article-title":"Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease","volume":"49","author":"Iturriaga","year":"2016","journal-title":"Biol. Res."},{"issue":"12","key":"10.1016\/j.pupt.2026.102450_bib8","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.046920","article-title":"Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease","volume":"13","author":"Noguchi","year":"2020","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","article-title":"Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine","volume":"151","author":"Dunham-Snary","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2026.102450_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-323-91534-2.00007-2","article-title":"Central respiratory chemoreception","volume":"188","author":"Guyenet","year":"2022","journal-title":"Handb. Clin. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.pupt.2026.102450_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.expneurol.2016.05.036","article-title":"Chemoreception and neuroplasticity in respiratory circuits","volume":"287","author":"Barnett","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pupt.2026.102450_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1422927","article-title":"Baroreflex and chemoreflex interaction in high-altitude exposure: possible role on exercise performance","volume":"15","author":"Alvarez-Araos","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pupt.2026.102450_bib13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3389\/fphys.2019.01505","article-title":"AltitudeOmics: spontaneous baroreflex sensitivity during acclimatization to 5,260 m: a comparison of methods","volume":"10","author":"Bourdillon","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pupt.2026.102450_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177152","article-title":"Macrophage-specific \u03ba-OR knockout exacerbates inflammation in hypoxic pulmonary hypertension","volume":"986","author":"Lu","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pupt.2026.102450_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yexcr.2017.03.034","article-title":"Mitochondria control acute and chronic responses to hypoxia","volume":"356","author":"McElroy","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.pupt.2026.102450_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000564","article-title":"Effect of continuous positive airway pressure therapy in patient with obstructive sleep apnea and pulmonary hypertension: a literature review","author":"Jain","year":"2023","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.pupt.2026.102450_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mam.2015.12.002","article-title":"Oxygen-sensing by arterial chemoreceptors: mechanisms and medical translation","volume":"47\u201348","author":"L\u00f3pez-Barneo","year":"2016","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.pupt.2026.102450_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-031-44757-0_7","article-title":"Neurochemical plasticity of the carotid body","volume":"237","author":"Lazarov","year":"2023","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib19","doi-asserted-by":"crossref","DOI":"10.2174\/0118743064344024250203101417","article-title":"Updates on pulmonary hypertension","volume":"19","author":"Paudyal","year":"2025","journal-title":"Open Respir. Med. J."},{"issue":"9","key":"10.1016\/j.pupt.2026.102450_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.pupt.2026.102450_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"Chin","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.pupt.2026.102450_bib22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.02.05542002","article-title":"The new clinical trials on pharmacological treatment in pulmonary arterial hypertension","volume":"20","author":"Gali\u00e8","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib23","article-title":"Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study","volume":"11","author":"Weatherald","year":"2024","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.pupt.2026.102450_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1217156","article-title":"Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review","volume":"10","author":"Alqarni","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.pupt.2026.102450_bib25","article-title":"Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review","volume":"10","author":"Alqarni","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.pupt.2026.102450_bib26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/eurheartj\/ehi807","article-title":"Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure","volume":"27","author":"Arias","year":"2006","journal-title":"Eur. Heart J."},{"issue":"38","key":"10.1016\/j.pupt.2026.102450_bib27","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.pupt.2026.102450_bib28","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.121.319970","article-title":"Group 3 pulmonary hypertension: from bench to bedside","volume":"130","author":"Singh","year":"2022","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.pupt.2026.102450_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/ph16030418","article-title":"Pharmacology and emerging therapies for group 3 pulmonary hypertension due to chronic lung disease","volume":"16","author":"Gonzales","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1-a Suppl","key":"10.1016\/j.pupt.2026.102450_bib30","first-page":"S2","article-title":"Shining a spotlight on pulmonary hypertension associated with interstitial lung disease care: the latest advances in diagnosis and treatment","volume":"31","author":"Nathan","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"issue":"8","key":"10.1016\/j.pupt.2026.102450_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101236","article-title":"Recent advances and future prospects of treatment of pulmonary hypertension","volume":"48","author":"Hajra","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12931-023-02346-0","article-title":"Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial","volume":"24","author":"Haeberle","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2026.102450_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.126882","article-title":"Nebulisation: an effective approach for delivering drugs to the heart","volume":"697","author":"Chowdhury","year":"2026","journal-title":"Int J Pharm"},{"issue":"4\u20136","key":"10.1016\/j.pupt.2026.102450_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/ars.2021.0255","article-title":"Mitochondrial redox signaling in O2-sensing chemoreceptor cells","volume":"37","author":"Gao","year":"2022","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"10.1016\/j.pupt.2026.102450_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/antiox14060675","article-title":"Reactive oxidative species in carotid body chemoreception: their role in oxygen sensing and cardiorespiratory alterations induced by chronic intermittent hypoxia","volume":"14","author":"Iturriaga","year":"2025","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.pupt.2026.102450_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.33549\/physiolres.932906","article-title":"ROS scavenger decreases basal perfusion pressure, vasoconstriction and NO synthase activity in pulmonary circulation during pulmonary microembolism","volume":"64","author":"Mizera","year":"2015","journal-title":"Physiol. Res."},{"issue":"6","key":"10.1016\/j.pupt.2026.102450_bib36","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3390\/ijms27062762","article-title":"Hypoxic pulmonary hypertension: molecular mechanisms and clinical research advances","volume":"27","author":"Fang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.pupt.2026.102450_bib37","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1172\/JCI137558","article-title":"Hypoxia-inducible factor signaling in pulmonary hypertension","volume":"130","author":"Pullamsetti","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib38","first-page":"1","article-title":"Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases","volume":"3","author":"Smola","year":"2008","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.pupt.2026.102450_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.38212\/2224-6614.3550","article-title":"Targeted nanosponge-based treatment for pulmonary hypertension: a novel approach","volume":"33","author":"Kaur","year":"2025","journal-title":"J. Food Drug Anal."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12951-026-04317-1","article-title":"From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertension","volume":"24","author":"Zhu","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.pupt.2026.102450_bib41","article-title":"Pulmonary hypertension: etiology and anti-inflammatory treatment pathways of natural products","volume":"16","author":"Li","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pupt.2026.102450_bib42","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/IJN.S451206","article-title":"Natural products-based inhaled formulations for treating pulmonary diseases","volume":"19","author":"Yong","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.pupt.2026.102450_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11906-019-0995-y","article-title":"Potential contribution of carotid body-induced sympathetic and renin-angiotensin system overflow to pulmonary hypertension in intermittent hypoxia","volume":"21","author":"Iturriaga","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/antiox11010054","article-title":"Maladaptive pulmonary vascular responses to chronic sustained and chronic intermittent hypoxia in rat","volume":"11","author":"Prieto-Lloret","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.pupt.2026.102450_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12201","article-title":"Right ventricular responses to CPAP therapy in obstructive sleep apnea: CMR analysis of the MOSAIC randomized trial","volume":"13","author":"Samaranayake","year":"2023","journal-title":"Pulm. Circ."},{"issue":"2","key":"10.1016\/j.pupt.2026.102450_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.31083\/j.rcm2502072","article-title":"Molecular mechanisms underlying vascular remodeling in hypertension","volume":"25","author":"Zeng","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.pupt.2026.102450_bib46","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1113\/JP282822","article-title":"Acute intermittent hypercapnic-hypoxia elicits central neural respiratory motor plasticity in humans","volume":"600","author":"Welch","year":"2022","journal-title":"J. Physiol."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455392600043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455392600043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:17:25Z","timestamp":1790295445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109455392600043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S109455392600043X"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102450","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting pulmonary and arterial chemoreceptors via inhaled therapeutics: A novel pathway to blunt hypoxia-induced pulmonary hypertension?","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102450"}}